We sought to determine the impact of chorioamnionitis exposure on term neonatal monocyte transcription. RNA-seq was performed on term healthy and chorioamnionitis-exposed umbilical cord blood purified CD14+ monocytes under unstimulated and LPS stimulated conditions. Overall design: RNA-seq on 11 samples with 2-3 replicates per exposure/stimulation group (each replicate contains 3 pooled samples)
Chorioamnionitis exposure remodels the unique histone modification landscape of neonatal monocytes and alters the expression of immune pathway genes.
Specimen part, Treatment, Subject
View SamplesFacioscapulohumeral muscular dystrophy (FSHD) is a progressive neuromuscular disorder caused by contractions of repetitive elements within the macrosatellite D4Z4 on chromosome 4q35. In order to develop mRNA-based biomarkers of affected muscles, we used GeneChip Gene 1.0 ST arrays for global analysis of gene expression in muscle biopsy specimens obtained from FSHD subjects and their unaffected first degree relatives.
Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers.
Sex, Specimen part, Disease, Disease stage, Subject
View SamplesInhibition of the myostatin signaling pathway is emerging as a promising therapeutic means to treat muscle wasting disorders. Activin type IIB receptor is the putative myostatin receptor, and a soluble activin receptor (ActRIIB-Fc) has been demonstrated to potently inhibit a subset of TGF- family members including myostatin. In order to determine reliable and valid biomarkers for myostatin pathway inhibition, we assessed gene expression profiles for quadriceps muscles from mice treated with ActRIIB-Fc compared to mice genetically lacking myostatin and control mice.
Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor.
Sex, Age, Specimen part, Treatment
View Samplesmolecular profiles (HG-U95B,C,D,E) of biopsy skeletal muscle samples obtained from 10 normal individuals and 10 DMD patients
Gene expression profiling of Duchenne muscular dystrophy skeletal muscle.
No sample metadata fields
View SamplesMolecular profiles of dystophin-deficient patients and normal human skeletal muscles on Affymetrix HG-U95A arrays
Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle.
No sample metadata fields
View SamplesThis study identified gene expression of Side Population (SP) and Main Population (MP) cells, isolated from adult murine skeletal muscle and Bone Marrow. Five different preparations of muscle SP, muscle MP, Bone marrw SP and Bone marrow MP cells were used as replicates.
Side population cells isolated from different tissues share transcriptome signatures and express tissue-specific markers.
No sample metadata fields
View SamplesThe goal of these studies was to determine the effects of fasting on skeletal muscle mRNA levels in healthy human subjects.
mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass.
Sex, Age, Specimen part, Treatment, Subject
View SamplesAnalysis of the transcriptome of zebrafish mononuclear myogenic cells (zMNCs) during myogenic differentiation. The main goal is to identify the similarities of zMNC myogenic differentiation with that of mammalian myoblast differentiation. Critical time points were used to identify a switch from the activity of cell proliferation genes to myogenic structural genes.
Isolation and transcriptome analysis of adult zebrafish cells enriched for skeletal muscle progenitors.
Specimen part, Time
View SamplesFragile X syndrome and tuberous sclerosis are genetic syndromes that both have a high rate of comorbidity with autism spectrum disorder (ASD). Several lines of evidence suggest that these two monogenic disorders may converge at a molecular level through the dysfunction of activity-dependent synaptic plasticity.
Divergent dysregulation of gene expression in murine models of fragile X syndrome and tuberous sclerosis.
Sex, Specimen part
View SamplesMuscle biopsies from biceps and deltoid were taken from 5 patients with FSHD, 5 asymptomatic carriers and 5 normal controls. The genome-wide expression patterns were compared using Affymetrix U133 Plus 2.0 chips.
Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers.
Sex, Age, Specimen part, Disease
View Samples